Clinical Trial Shows Berlin Heart, Inc.’s EXCOR® Pediatric Ventricular Assist Device (VAD) Successfully Bridged 90% of Children with Severe Heart Failure Who Were Waiting for a Heart Transplant

THE WOODLANDS, Texas & BERLIN--(BUSINESS WIRE)--The Berlin Heart Group announced today that clinical trial data were presented this morning at the “Scientific Sessions 2011” annual meeting of the American Heart Association (AHA). These data showed that, in a clinical trial of children with severe heart failure who were waiting for a heart transplant, 90% of patients in the primary cohort of the study were successfully bridged to a heart transplant using Berlin Heart’s EXCOR® Pediatric Ventricular Assist Device (VAD).